4 Stocks Under $10 Soaring in a Weak Tape

>>6 Stocks to Play for Lower Gold Prices

From a technical perspective, AUMN is bouncing hard here off of some previous support levels near $3.24, and off of extremely oversold conditions. The current RSI reading for AUMN is 35.08, which indicates an oversold stock. Nothing says oversold more than the chart for AUMN, can shares have dropped from its February high of $10.60 to its recent low of $3.24.

Traders should now look for long-biased traders if AUMN can manage to trigger a near-term breakout trade. That trade will hit once AUMN takes out some near-term overhead resistance at $3.98 with high volume. Look for a sustained move or close above $3.98 with volume that's near or above 266,002 shares. If we get that action soon, look for AUMN to spike big, possibly back toward some resistance at $5 or even its 50-day moving average of $6.08. Synta Pharmaceuticals

Synta Pharmaceuticals(SNTA) is a biopharmaceutical company. Synta Pharmaceuticals is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases. This stock is trading up 4.5% at $5.03 in recent trading.

Today's Range: $4.58-$5.08